What is the average fentanyl content in street‑bought counterfeit M30 (oxycodone) tablets, what percentage of these counterfeit tablets actually contain oxycodone as the active ingredient, and how do fentanyl and oxycodone interact pharmacologically?

Counterfeit M30 Pills: Fentanyl Content and Oxycodone Presence

The vast majority of street-bought counterfeit "M30" oxycodone pills contain fentanyl (approximately 30-75% of samples tested), while virtually none contain actual oxycodone as the active ingredient. When both fentanyl and oxycodone are present together, they produce synergistic respiratory depression that dramatically increases overdose risk.

Fentanyl Content in Counterfeit M30 Pills

Prevalence and Composition

• 29.6% of pills sold as "oxycodone" contained fentanyl in Mexican pharmacy samples 1
• 75.4% of counterfeit pills contained fentanyl in Washington D.C. surveillance 2
• By 2021,62.5% of all pharmaceutical submissions were counterfeit, with fentanyl as the predominant adulterant 2

The amount of fentanyl per pill is highly variable and unpredictable—this inconsistency is what makes these pills so deadly. Unlike pharmaceutical manufacturing with precise dosing, illicit production results in "hot spots" where some pills contain lethal amounts while others in the same batch may contain little to none.

Additional Concerning Findings

Beyond fentanyl, counterfeit M30 pills have been found to contain:

• Heroin (3 samples in the Mexican pharmacy study) 1
• Novel benzodiazepines 2
• Other synthetic opioids and precursors 2

Oxycodone Presence: Essentially Zero

Counterfeit M30 pills essentially never contain actual oxycodone. The evidence shows:

• Studies analyzing counterfeit pills found fentanyl, heroin, methamphetamine, and novel benzodiazepines—but no mention of actual oxycodone being present 1, 2
• The term "counterfeit" specifically means these pills are designed to look like pharmaceutical oxycodone but contain entirely different substances 3
• 91.6% of exposure cases involved additional substances beyond what was expected, indicating complete substitution rather than adulteration 3

The manufacturing economics explain this: fentanyl is far cheaper to produce than diverting or synthesizing actual oxycodone, making pure substitution the norm rather than mixing.

Pharmacological Interaction: Fentanyl + Oxycodone

If both drugs were present simultaneously, they would produce synergistic—not merely additive—respiratory depression, creating extreme overdose risk.

Mechanism of Synergistic Toxicity

Both fentanyl and oxycodone are mu-opioid receptor agonists that:

• Depress respiratory centers in the brainstem 4, 5
• Reduce the ventilatory response to hypoxia and hypercapnea 4
• Act on the same receptor system but with different pharmacokinetic profiles

Why This Combination Is Particularly Dangerous

Fentanyl characteristics 5, 6:

• Extremely rapid onset (1-2 minutes IV/intranasal)
• High lipid solubility allowing quick CNS penetration
• 50-100 times more potent than morphine
• Can cause chest wall rigidity at higher doses, making ventilation difficult
• Accumulates in fat and muscle with repeated dosing

Oxycodone characteristics 7:

• Longer duration of action (3-5 hours)
• Acts at mu-, delta-, and kappa-opioid receptors
• Oral bioavailability allows sustained effect

Combined effect: The rapid, intense respiratory depression from fentanyl would be prolonged and intensified by oxycodone's longer duration. The guideline evidence is explicit: "The concomitant use of a barbiturate or benzodiazepine with an opioid has a synergistic effect on the risk of respiratory depression" 5—the same principle applies to combining two opioids, particularly when one is as potent as fentanyl.

Clinical Implications

Conversion factors demonstrate the danger 8, 9:

• Oxycodone conversion factor: 1.5 (meaning 10mg oxycodone = 15 MME)
• Fentanyl transdermal conversion factor: 2.4 per mcg/hr
• Just 100 mcg of fentanyl equals approximately 10mg IV morphine 7

A person expecting a 30mg oxycodone pill (45 MME) who instead receives an unknown amount of fentanyl faces:

• Unpredictable potency (could be 10x-100x stronger than expected)
• Rapid onset leaving minimal time for intervention
• Potential for chest wall rigidity making naloxone rescue more difficult 5

Naloxone Considerations

Higher and repeated doses of naloxone are required for fentanyl overdoses 5:

• Initial dose: 0.4-2mg IV/IM/intranasal
• May require repeated dosing every 2-3 minutes due to fentanyl's high receptor affinity
• Observation for 2+ hours is mandatory as fentanyl's duration may outlast naloxone 4, 5
• With transdermal fentanyl, serum levels decline slowly (50% in ~17 hours) due to continued skin absorption 6

Critical Clinical Pitfalls

1. Visual identification is impossible: Counterfeit pills are "indistinguishable from authentic pharmaceuticals" 1, 10

2. Geographic proximity doesn't help: "Identically-appearing authentic and counterfeit versions were often sold in close geographic proximity" 1

3. Younger populations are disproportionately affected: 67.4% of exposure cases were ages 15-34 3

4. ICU admission is common: 69% of hospitalized patients required intensive care 3

5. Patients may be opioid-naïve: Many consumers "would be unlikely to consume those drugs knowingly" and have no opioid tolerance 10